Alphatec Holdings Inc Revenue Growth Rates (ATEC), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Alphatec Holdings Inc   (NASDAQ: ATEC)
 

ATEC's Revenue Growth by Quarter and Year

Alphatec Holdings Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/ATEC/growth
https://api.csimarket.com/api/v1/companies/ATEC/fundamentals
https://api.csimarket.com/api/v1/companies/ATEC/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
ATEC Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 221.17
2nd Quarter June 213.51
1st Quarter March 191.48
FY 626.16

ATECs Annual Revenue
Alphatec Holdings Inc 's Revenue in the fiscal year 2025 $ 763.89 millions
Alphatec Holdings Inc 's Revenue in the fiscal year 2024 $ 611.26 millions
Alphatec Holdings Inc 's Revenue in the fiscal year 2023 $ 482.20 millions
Alphatec Holdings Inc 's Revenue in the fiscal year 2022 $ 350.87 millions
Alphatec Holdings Inc 's Revenue in the fiscal year 2021 $ 243.21 millions




ATEC Revenue third quarter 2026 Y/Y Growth Comment
Alphatec Holdings Inc reported Revenue increase of 12.67% year on year in the third quarter 2026, to $ 221.17 millions, this is lower than Alphatec Holdings Inc 's recent average Revenue increase of 13.52%.

Looking into third quarter 2026 results within Medical Equipment & Supplies industry 71 other companies have achieved higher Revenue growth. While Alphatec Holdings Inc ' s Revenue growth of 12.67% ranks overall at the positon no. 1281 in the third quarter 2026.


ATEC Revenue ( Y/Y Growth %) 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 12.67 %
2nd Quarter June 15.35 %
1st Quarter March 13.3 %
FY   -

Financial Statements
Alphatec Holdings Inc 's third quarter 2026 Revenue $ 221.17 millions ATEC's Income Statement
Alphatec Holdings Inc 's third quarter 2025 Revenue $ 196.30 millions Quarterly ATEC's Income Statement


ATEC Revenue (Quarter on Quarter Growth %)

 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 3.59 %
2nd Quarter June 11.51 %
1st Quarter March -10.31 %
FY (Year on Year)   -


Back to ATEC Growth rate Comparisons >> Back to ATEC Growth rate Comparisons >>


Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #72
Healthcare Sector #228
Overall #1281

Revenue Y/Y Growth Statistics
High Average Low
110.09 % 13.52 % -39.19 %
(Mar 31 2022)   (Dec 31 2017)
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #72
Healthcare Sector #228
Overall #1281
Revenue Y/Y Growth Statistics
High Average Low
110.09 % 13.52 % -39.19 %
(Mar 31 2022)   (Dec 31 2017)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Alphatec Holdings Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
41.09 % 3.01 % -33.66 %
(Jun 30 2021)  


ATEC's III. Quarter Q/Q Revenue Comment
Alphatec Holdings Inc achieved in the III. Quarter 2026 above company average sequential Revenue growth of 3.59%, to $ 221.17 millions, from $213.51 millions in the second quarter.

Within Medical Equipment & Supplies industry 32 other companies have achieved higher Revenue quarter on quarter growth. While Alphatec Holdings Inc 's Revenue growth quarter on quarter, overall rank is 759.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #33
Healthcare Sector #123
Overall #759
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #33
Healthcare Sector #123
Overall #759
Revenue Q/Q Growth Statistics
High Average Low
41.09 % 3.01 % -33.66 %
(Jun 30 2021)  


ATEC's III. Quarter Q/Q Revenue Comment
Alphatec Holdings Inc achieved in the III. Quarter 2026 above company average sequential Revenue growth of 3.59%, to $ 221.17 millions, from $213.51 millions in the second quarter.

Within Medical Equipment & Supplies industry 32 other companies have achieved higher Revenue quarter on quarter growth. While Alphatec Holdings Inc 's Revenue growth quarter on quarter, overall rank is 759.


Alphatec Holdings Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2026)		 12 Months Ending (Jun 30 2026) 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025)
Cumulative Revenue 12 Months Ending $ 839.65
Y / Y Revenue Growth (TTM) 15.18 %
Year on Year Revenue Growth Overall Ranking # 646
Seqeuential Revenue Change (TTM) 3.05 %
Seq. Revenue Growth (TTM) Overall Ranking # 1928


Cumulative Revenue growth Comment
Assuming the Alphatec Holdings Inc 's fiscal year would have ended in Sep 30 2026, Alphatec Holdings Inc would have reprted above average annual Revenue increase of 15.18% year on year, of $ 840 millions.
This marks a slow-down of the companys growth trends and from the 19.4% rise in Jun 30 2026.

In the Healthcare sector 133 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 528 to 646.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 110
Healthcare Sector # 134
Overall # 646

Revenue TTM Y/Y Growth Statistics
High Average Low
69.97 %
 13.14 %
-35.07 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 110
Sector # 301
S&P 500 # 1928
Cumulative Revenue growth Comment
Assuming the Alphatec Holdings Inc 's fiscal year would have ended in Sep 30 2026, Alphatec Holdings Inc would have reprted above average annual Revenue increase of 15.18% year on year, of $ 840 millions.
This marks a slow-down of the companys growth trends and from the 19.4% rise in Jun 30 2026.

In the Healthcare sector 133 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 528 to 646.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 110
Healthcare Sector # 134
Overall # 646

Revenue TTM Y/Y Growth Statistics
High Average Low
69.97 %
13.14 %
-35.07 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 110
Sector # 301
S&P 500 # 1928




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ATEC's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue rise for the quarter ending Sep 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Veracyte Inc 22.10%$ 22.105 millions
Radnet Inc 22.07%$ 22.068 millions
Alkermes Plc 21.80%$ 21.804 millions
Alpha Teknova Inc 21.52%$ 21.523 millions
Anteris Technologies Global Corp 20.98%$ 20.979 millions
Trisalus Life Sciences Inc 20.81%$ 20.807 millions
Orthopediatrics Corp20.55%$ 20.551 millions
Alpha Pro Tech Ltd 19.73%$ 19.729 millions
Insulet Corporation19.21%$ 19.213 millions
Abcellera Biologics Inc 18.81%$ 18.805 millions
Schrodinger Inc 18.72%$ 18.715 millions
Procept Biorobotics Corporation18.41%$ 18.414 millions
Supernus Pharmaceuticals inc 18.05%$ 18.047 millions
Outset Medical Inc 17.51%$ 17.510 millions
Alnylam Pharmaceuticals Inc 16.74%$ 16.738 millions
IMPACT BIOMEDICAL INC.16.67%$ 16.667 millions
Rigel Pharmaceuticals Inc16.45%$ 16.452 millions
Si bone inc 16.42%$ 16.424 millions
Ars Pharmaceuticals Inc 16.03%$ 16.027 millions
Atricure Inc 15.84%$ 15.839 millions
Ardelyx inc 15.70%$ 15.704 millions
Novocure Limited15.67%$ 15.666 millions
Penumbra Inc15.64%$ 15.636 millions
Orasure Technologies Inc15.45%$ 15.445 millions
Electromed Inc 15.34%$ 15.342 millions
Irhythm Holdings Inc 15.34%$ 15.339 millions
P3 Health Partners Inc 14.80%$ 14.798 millions
Msa Safety Inc14.72%$ 14.716 millions
Ensign Group Inc14.47%$ 14.471 millions
Abbott Laboratories14.46%$ 14.460 millions


About Alphatec Holdings Inc Revenue Growth Rates (ATEC), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Alphatec Holdings Inc (CIK 1350653).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001193125-26-438050
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Alphatec Holdings Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.